Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication regarding Meeting of Board of Directors of the Company scheduled to be held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges about a board meeting scheduled for Friday, May 30, 2025 at its Hyderabad corporate office. The board will consider and approve the audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2025, along with the statutory auditors' report. This filing is a procedural submission of the newspaper notice that was already published in Business Standard and Saksham (a Telugu local newspaper) on May 21, 2025, as required under SEBI's Listing Regulations. No actual financial numbers have been disclosed in this filing — those will come after the board meeting.
This is a routine regulatory compliance filing and does not contain any new financial information. Shareholders should watch for the actual Q4 and FY25 results announcement expected on or shortly after May 30, 2025, which could move the stock depending on the numbers.